07 Nov Inactivation of Capicua confers resistance to MAPK pathway inhibition but exposes selective vulnerabilities in KRAS mutant lung cancer cells
Posted at 10:53h
in DRUG TOLERANCE
ID: 03427
Authors: Ballesteros, Irene (1,2); Brehey, Oksana (3); G. Lechuga, Carmen (3); Scotece, Morena (1,2); Flores, Alejandra (1,2); Blanco, Carmen (4); Barbacid, Mariano (3); Drosten, Matthias (1,2)
Topic: DRUG TOLERANCE
Read